Contemporary blood doping: Performance, mechanism, and detection

Andreas Breenfeldt Andersen*, Nikolai Baastrup Nordsborg, Thomas Christian Bonne, Jacob Bejder*

*Corresponding author for this work

Research output: Contribution to journalReviewResearchpeer-review

5 Citations (Scopus)
39 Downloads (Pure)

Abstract

Blood doping is prohibited for athletes but has been a well-described practice within endurance sports throughout the years. With improved direct and indirect detection methods, the practice has allegedly moved towards micro-dosing, i.e., reducing the blood doping regime amplitude. This narrative review evaluates whether blood doping, specifically recombinant human erythropoietin (rhEpo) treatment and blood transfusions are performance-enhancing, the responsible mechanism as well as detection possibilities with a special emphasis on micro-dosing. In general, studies evaluating micro-doses of blood doping are limited. However, in randomized, double-blinded, placebo-controlled trials, three studies find that infusing as little as 130 ml red blood cells or injecting 9 IU × kg bw-1 rhEpo three times per week for four weeks improve endurance performance ~4-6 %. The responsible mechanism for a performance-enhancing effect following rhEpo or blood transfusions appear to be increased O2 -carrying capacity, which is accompanied by an increased muscular oxygen extraction and likely increased blood flow to the working muscles, enabling the ability to sustain a higher exercise intensity for a given period. Blood doping in micro-doses challenges indirect detection by the Athlete Biological Passport, albeit it can identify ~20-60% of the individuals depending on the sample timing. However, novel biomarkers are emerging, and some may provide additive value for detection of micro blood doping such as the immature reticulocytes or the iron regulatory hormones hepcidin and erythroferrone. Future studies should attempt to validate these biomarkers for implementation in real-world anti-doping efforts and continue the biomarker discovery.

Original languageEnglish
Article numbere14243
JournalScandinavian Journal of Medicine & Science in Sports
Volume34
Issue number1
Number of pages15
ISSN0905-7188
DOIs
Publication statusPublished - 2024

Bibliographical note

This article is protected by copyright. All rights reserved.

Keywords

  • Faculty of Science
  • Micro blood doping
  • Exercise
  • Antidoping
  • Blood manipulation
  • Low volume
  • Blood transfusion
  • Recombinant human erythropoietin

Cite this